JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway
Li Zhang , Yong-Yu Yang , Li Xie , Yuan Zhou , Zhenxing Zhong , Jia Ding , Zhong-Hua Wang , Yu-Li Wang , Xiu-Ping Liu , Fa-Xing Yu , Jian Wu
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (3) : e1630
JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway
• JCAD deficiency leads to an impaired liver growth after PH due to cell division blockage. • JCAD competes with LATS2 for WWC1 interaction, resulting in LATS2 inhibition, YAP activation and enhanced expression of cell cycle-associated genes. • Delineation of JCADHippoYAP signalling pathway would facilitate to improve prognosis of acute liver failure and graft growth in living-donor liver transplantation.
cell cycle phase visualisation / Hippo–YAP signalling pathway / JCAD / liver regeneration / WWC1
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |